Camad, Nadzman .

HRN: 21-88-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2025
CEFUROXIME 1.5GM (VIAL)
10/04/2025
10/04/2025
IV
1500mg
On Call To OR
For CS
Waiting Final Action 
10/04/2025
CEFUROXIME 1.5GM (VIAL)
10/04/2025
10/05/2025
IVT
1.5GMS
Q8
LTCS
Waiting Final Action 
10/04/2025
CEFUROXIME 500MG (TAB)
10/06/2025
10/13/2025
PO
500 MG
BID
NKA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: